Evidence map›Paper›PMID 39915032›Full record

ArticleBMJ open2025

Annual versus biannual azithromycin mass drug administration for the elimination of infectious trachoma in Africa: protocol for a systematic review and meta-analysis using data from individual communities.

Taye Zeru, Jeremy David Keenan, Solomon Aragie, Getu Degu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Taye ZeruAmhara Public Health Institute, Bahir Dar, Amhara, Ethiopia zerutaye@gmail.com.ORCID http://orcid.org/0000-0003-0736-2955
Jeremy David KeenanFrancis I Proctor Foundation and Department of Ophthalmology, University of California, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-7118-1457
Solomon AragieAddis Ababa University, Addis Ababa, Ethiopia.
Getu DeguBahir Dar University College of Medical and Health Sciences, Bahir Dar, Amhara, Ethiopia.

Funding

Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II)UG1EY023939 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KEENAN, JEREMY DAVID · 2019 to 2023
$4.1M
NEI NIH HHS UG1 EY023939
6 · The paper itself

Abstract

introductionTrachoma is an infectious eye disease caused by METHODS AND ANALYSIS: PubMed, Embase, Web of Science, Scopus and Google Scholar will be searched for studies comparing annual and biannual mass azithromycin distributions for trachoma. Community-level data will be extracted using a standardised data extraction form. Authors will be asked to contribute community-level data not available in the manuscript. The main outcome will be ETHICS AND DISSEMINATION: The research will use community-aggregated data and is thus exempt from ethical approval. The results will be submitted for publication in a peer-reviewed journal. PROSPERO REGISTRATION NUMBER: CRD42024526120.

Indexed as

Anti-Bacterial AgentsAzithromycinMass Drug AdministrationTrachomaAfricaChildChild, PreschoolChlamydia trachomatisHumansInfantMeta-Analysis as TopicResearch DesignSystematic Reviews as TopicAnti-Bacterial AgentsAzithromycinChildORAL MEDICINERandomised Controlled Trial

Identifiers

PMID39915032
PMCPMC11815427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.